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Abstract
Background/aim: Autophagy is a macromolecular degradation process playing a pivotal role in the maintenance
of stem-like features and in the morpho-functional remodeling of the tissues undergoing differentiation. In this
work we investigated the involvement of autophagy in the osteogenic differentiation of mesenchymal stem cells
originated from human gingiva (HGMSC). METHODS: To promote the osteogenic differentiation of HGMSCs we
employed resveratrol, a nutraceutical known to modulate autophagy and cell differentiation, together with
osteoblastic inductive factors. Osteoblastic differentiation and autophagy were monitored through western blotting
and immunofluorescence staining of specific markers.
Results: We show that HGMSCs can differentiate into osteoblasts when cultured in the presence of appropriate
factors and that resveratrol accelerates this process by up-regulating autophagy. The prolonged incubation with
dexamethasone, β-glycerophosphate and ascorbic acid induced the osteogenic differentiation of HGMSCc with
increased expression of autophagy markers. Resveratrol (1 μM) alone elicited a less marked osteogenic
differentiation yet it greatly induced autophagy and, when added to the osteogenic differentiation factors, it
provoked a synergistic effect. Resveratrol and osteogenic inductive factors synergistically induced the AMPK-BECLIN-
1 pro-autophagic pathway in differentiating HGMSCs, that was thereafter downregulated in osteoblastic
differentiated cells. Pharmacologic inhibition of BECLIN-1-dependent autophagy precluded the osteogenic
differentiation of HGMSCs.
Conclusions: Autophagy modulation is instrumental for osteoblastic differentiation of HGMSCs. The present
findings can be translated into the regenerative cell therapy of maxillary / mandibular bone defects.
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Background
Bone resorption, bone wound healing and osteo-integra-
tion of implants remain major clinical challenges in ortho-
pedics and dentistry. An attractive solution is exploiting
the regenerative potential of Mesenchymal Stem Cells
(MSCs) isolated from adult tissues that could differentiate
into osteoblasts and chondrocytes [1–3]. In this context,
interest recently arose for MSCs from the lamina propria
of the gingiva (GMSCs), that represents an easily
accessible source from which MSCs can be isolated with
minimally invasive techniques [4–6]. GMSCs can be prop-
agated in vitro for long-time while maintaining a stable
phenotype and can be induced to differentiate into the
osteogenic lineage employing a variety of substances, in-
cluding herbal-derived polyphenols [7–11].
Recently, interest arose for the potential of resveratrol
(RV, trans 3,5,4′ trihydroxy-stylbene), a naturally occur-
ring polyphenol, to prevent and cure bone loss-related dis-
eases [12, 13]. RV shows anti-inflammatory [14] and anti-
osteoclastic activities [15, 16] while showing osteoblastic
differentiation promoting activities on MSCs [17–21].
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However, the osteogenic response to RV has not been
tested yet in human GMSCs (HGMSCs).
Stem cell differentiation implies a morpho-func-
tional remodeling of the cell that is accomplished
through dynamic and coordinated processes of macro-
molecular degradation and synthesis along with tran-
scriptional and epigenetic reprogramming [22–24].
Macromolecular degradation in stem cells undergoing
differentiation occurs via macro-autophagy (now on
simply autophagy), which consists in the entrapment
of cellular components such as organelles, membranes
and cytosolic proteins within a double-membrane
vesicle (the autophagosome) that will eventually fuse
with lysosomes to form an autolysosome wherein the
substrates will be degraded to completion [24, 25].
Autophagy is a stress-response and homeostatic
process that plays a pivotal role in bone homeostasis
[26]. However, whether and how autophagy is impli-
cated in the osteogenic differentiation of MSCs re-
mains to be elucidated yet. Here, we have investigated
the functional role and the regulation of autophagy
during the osteogenic differentiation of HGMSCs
using RV as an inducer of autophagy [27] and of
osteogenic differentiation of MSCs [18] at the same
time. We show that RV synergizes with osteogenic in-
ductive factors to accelerate the osteogenic differenti-
ation of HGMSCs and that this effect is strictly
dependent on the modulation of autophagy.
Methods
Isolation of human gingival mesenchymal stem cells
Human Gingival Mesenchymal Stem Cells (HGMSCs)
were isolated from gingival tissue samples of adult
healthy patients undergoing orthodontic surgery proce-
dures. Each subject gave written informed consent, in
accordance with the Helsinki Declaration, before their
inclusion in the study. The Ethical Committee of Padova
Hospital (Padova, Italy) approved the research protocol.
After collection, gingival biopsies were briefly washed
with Phosphate Buffered Saline (PBS; EuroClone, Milan,
Italy), minced, then enzymatically digested with a solu-
tion of 3 mg/mL collagenase type I (Sigma-Aldrich, Saint
Louis, MO, USA) and 4mg/mL dispase (Sigma-Aldrich)
in PBS for 2 h at 37 °C, as described elsewhere [28].
Once digested, the solution was filtered through 70mm
Falcon strainers (Becton & Dickinson, Franklin Lakes,
NJ). The isolated cells were then cultured with Dulbec-
co’s Modified Eagle’s Medium (DMEM) high glucose
(EuroClone), supplemented with 10% Fetal Bovine
Serum (FBS; EuroClone), and 1% penicillin/streptomycin
(P/S; EuroClone). Culture medium was refreshed twice a
week. At 80–90% confluence, cells were detached with
trypsin-EDTA solution (Sigma-Aldrich) and passaged
repeatedly.
Characterization of HGMSCs by flow cytometry
Adherent cells at passage 3 were dissociated and resus-
pended in flow cytometry staining buffer (R&D Systems,
Minneapolis, MN, USA) at a final cell concentration of
1 × 106 cells/mL. For surface markers characterization,
the following fluorescent monoclonal mouse anti-human
antibodies were used: CD73 APC (eBioscience™, Thermo
Fisher Scientific, San Diego, CA, USA), CD90 BV510
(BD Biosciences, San Jose, CA, USA), CD105 PE-Cya-
nine7 (eBioscience™), CD14 PE (eBioscience™), CD34
APC-eFluor 780 (eBioscienceTM), and CD45 Pacific
Orange (Thermo Fisher Scientific), as published
elsewhere [29]. Cells were washed twice with 2 mL of
flow cytometry staining buffer and resuspended in
500 μL of flow cytometry staining buffer. Fluorescence
was evaluated by flow cytometry in Attune NxT flow
cytometer (Thermo Fisher Scientific). Data were ana-
lyzed using Attune NxT software (Thermo Fisher
Scientific).
Cell culture and reagents
HGMSCs were cultivated under standard conditions
(37 °C, 95% air: 5% CO2 v/v) in α-Minimum Essential
Medium Eagle (α-MEM, Cod. M8042, Sigma-Aldrich, St.
Luis, MO, USA) supplemented with 10% heat-inacti-
vated Fetal Bovine Serum (FBS, cod. ECS0180L; Euro-
clone S.p.A., Milan, Italy), 2 mM L-glutamine (cod.
G7513, Sigma-Aldrich) and 1% w/v of Penicillin/Strepto-
mycin (cod. P0781, Sigma-Aldrich). For osteogenic dif-
ferentiation, cells were incubated up to 21 days in α-
MEM supplemented with 50 μg/mL of L-ascorbic acid
2-phosphate (Cod. 49,752, Sigma-Aldrich), 100 nM of
dexamethasone (Cod. D1756, Sigma-Aldrich), and 10
mM of β-glycerophosphate (Cod. G9422, Sigma-Aldrich)
(referred to as ‘differentiation medium’) [30]. Differenti-
ation medium was replaced twice or thrice a week by
adding all previous reagents. Resveratrol (RV, Cod.
R5010, Sigma-Aldrich) was added to the standard or
differentiation medium as indicated. Where reported,
5 μM spautin-1 (Sp1, Cod. SML0440, Sigma-Aldrich)
was added to the culture medium.
HGMSCs were seeded on 35mm Petri dishes at
80.000 cells per dish or on sterile glass coverslips at
10.000 cells per dish for western blot and immunofluor-
escence analysis, respectively. For histochemical staining
with Alizarin Red Staining, the cells were cultured on
24-well plates at 20.000 cells per well and let adhere 24
h before treatments.
Antibodies
The following primary antibodies were employed for
western blotting and immunofluorescence techniques:
rabbit monoclonal anti-RUNX2 (Cod. 12,556, Cell Sig-
naling Technology Inc., Danvers, MA, USA), rabbit
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polyclonal anti-collagen Type 1 alpha 1 (Cod. NB600–
408, Novus Biological Centennial, USA), mouse monoclo-
nal anti-osteopontin (Cod. MA5–17180, Thermo Fisher
Scientific Inc., Waltham, MA, USA), mouse monoclonal
anti-osteocalcin (Cod. sc-74,495, Santa Cruz Biotechnol-
ogy Inc., Dallas, TX, USA), mouse monoclonal anti-
beclin-1 (Cod. 612,112, BD Biosciences, San Jose, CA,
USA), rabbit monoclonal anti-phospho-beclin-1 (Ser93)
(Cod. 14,717, Cell Signaling Technology Inc.), rabbit
monoclonal anti-PI3 Kinase Class III (Vps34, Cod. 4263,
Cell Signaling Technology Inc.), rabbit polyclonal anti-
LC3B (Cod. L7543, Sigma-Aldrich), mouse monoclonal
anti-β-tubulin (Cod. T5293, Sigma-Aldrich Corp.), mouse
monoclonal anti- β-actin (Cod. A5441, Sigma-Aldrich),
mouse monoclonal anti-LAMP1 (Cod. 555,798, Becton,
Dickinson and Company, New Jersey, NJ, USA), rabbit
polyclonal anti-AMPKα (Cod. 2532, Cell Signaling Tech-
nology Inc.) and rabbit monoclonal anti-phospho-AMPKα
(Thr172) (Cod. 2535, Cell Signaling Technology Inc.).
Western blotting
HGMSCs were homogenized in RIPA buffer (0.5% deoxy-
cholate, 1% NP-40, 0.1% Sodium Dodecyl Sulfate in PBS
solution) supplemented with protease inhibitor cocktail
and phosphatase inhibitors (Na3VO4 and NaF). Proteins
were determined by Bradford assay, denatured with 5X
Loading buffer at 95 °C for 10min and fractionated by
SDS-PAGE at different acrylamide percentage (15, 12.5,
8% or 6%) according to the m.w. of the target protein. Mo-
lecular weight markers were PageRuler Prestained Protein
Ladder (Cod. 26,616, Thermo Fisher Scientific Inc.) for 15
and 12.5% gels, and Spectra Multicolor High Range Pro-
tein Ladder (cod. 26,625, Thermo Fisher Scientific Inc.)
for 8 and 6% gels. After PAGE, the proteins were blotted
onto PVDF membranes (cod. 162–0177, Bio-Rad,
Hercules, CA, USA). Membranes were blocked with 5%
non-fat milk (cod. 68,514–61-4, SERVA Electrophoresis
GmbH, Heidelberg, Germany) containing 0.2% Tween-20
for 1 h at room temperature (RT), incubated with specific
primary antibody overnight at 4 °C and, thereafter, with
the secondary HRP-conjugated antibody for at least 1 h at
RT. β-tubulin and β-actin were used as homogenate
protein loading control. Membranes were developed with
the enhanced chemiluminescence method (ECL, cod.
NEL103E001 EA; PerkinElmer Inc., Waltham, MA, USA).
The relative band intensity was acquired with the Versa-
DOC Imaging System apparatus (Bio-Rad) and quantified
by Quantity One 4.5.0 software (Bio-Rad). At least three
independent replicates per each western blot were
performed.
Immunofluorescence
HGMSCs plated on sterile coverslips were incubated as
indicated. At the end, the cells were washed with PBS,
fixed with ice-cold 100% methanol and permeabilized
with 0.2% Triton X-100 in PBS for 10 min. Then, cells
were incubated with the specific primary antibodies
overnight at 4 °C. The following day, the coverslips were
washed with 0.1% Triton X-100 in PBS and incubated
for 1 h at RT with goat-anti-rabbit IgG Alexa Fluor™ plus
488 (Cod. A32731, Thermo Fisher Scientific Inc.) or
goat-anti-mouse IgG Alexa Fluor™ plus 555 (Cod.
A32727, Thermo Fisher Scientific Inc.) secondary anti-
bodies, as appropriate. Nuclei were stained with DAPI
(4′,6-diamidino-2-phenylindole, cod. 32,670, Sigma-Al-
drich Corp.). Thereafter, coverslips were mounted onto
glasses using slow-FADE anti-FADe reagent (Cod.
S36936, Life Technologies Ltd) and fluorescence images
were acquired with the Leica DMI6000 fluorescence
microscope (Leica Microsystems AG, Wetzlad, DE). The
fluorescence intensity was measured by Image-J 1.48v
software (http://imagej.nih.gov/ij/) and indicated as
IntDen, for either single channel and co-labelling (red +
green = yellow). IntDen (Integrated Density) refers to the
average value of fluorescence in a selected area normal-
ized to the number of cells. At least three slides were
prepared for each experimental condition and fluores-
cence in up to 100–200 cells in total present in six to
ten microscopic fields randomly chosen was quantified.
Images shown are representative of at least three separ-
ate experiments.
Assessment of osteogenic differentiation
The presence of calcium deposition in the extracellular
matrix, a sign of osteoblastic activity, was detected by
Alizarin Red S staining [31]. At the end of incubation in
medium containing or not the osteogenic differentiation
factors and/or resveratrol, the cell culture was washed
with PBS, fixed in 10% formaldehyde for 30 min at room
temperature (RT), rinsed twice with deionized water and
stained with 40mM Alizarin Red S (Cod. TMS-008-C,
Sigma-Aldrich), pH 4.1, for 45 min at RT. Then, the
cultures were washed four times with deionized water to
remove non-specifically bound stain. After drying,
stained monolayers were observed and imaged under the
phase microscope. The area of calcium deposits, indi-
cated as Calcium Deposition (% Area), was calculated
using the Image-J 1.48v software.
Statistics
All experiments were performed at least three times,
separately. Data in histograms are shown as average ±
S.D. GraphPad Prism was employed (GraphPad Software
Inc.) for statistical analysis. Statistical significance of the
data was given by one-way ANOVA analysis of variance
followed by Tukey’s test. Differences were considered
significant for *p < 0.05; **p < 0.01; ***p < 0.001.
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Results
Characterization of human gingival mesenchymal stem
cells
The HGMSCs isolated from the gingival samples were
characterized according to their surface protein expres-
sion by flow cytometry. As shown in Fig. 1, the cells
were found positive for the established MSCs-specific
surface markers CD73, CD90, and CD105 [32]. Flow cy-
tometry immunophenotyping also revealed the negativity
to CD14, CD34, and CD45, confirming the absence of
hematopoietic cells in the isolated stem cells population.
Resveratrol promotes the osteogenic differentiation of
human gingival mesenchymal stem cells
To determine the optimal conditions for osteogenic differ-
entiation by RV, HGMSCs were incubated for up to 21
days with RV in concentration ranging from 1 to 100 μM.
As positive control, the cells were incubated in a medium
Fig. 1 Isolation and characterization of Human Gingival Mesenchymal Stem Cells. Characterization of cell surface markers in HGMSCs at passage 3
by flow cytometry. The stem cells isolated from the gingival biopsies are positive to CD73, CD90, and CD105 MSCs-specific markers, and negative
to CD14, CD34, and CD45 hematopoietic markers
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supplemented with the osteogenic differentiation factors
dexamethasone, β-glycerophosphate and ascorbic acid
(from now on, referred as ‘differentiation medium’). To
monitor the mineralization associated with osteogenic dif-
ferentiation of HGMSCs the cultures were stained with
Alizarin Red S to detect the calcium deposits in the extra-
cellular space. The mineralization was clearly detectable
after a minimum of 7–14 days culture in differentiation
medium (not shown). Representative images in Fig. 2 (and
relative quantification) show that the osteogenic differenti-
ation promoted by RV is maximal at 1 μM and declines
when concentration raises up to 100 μM, which turned out
to be toxic. When 1 μM RV was added to the differenti-
ation medium, osteogenic differentiation of HGMSCs (as
mirrored by the mineralization of the extracellular matrix)
was accelerated, indicating a synergism between RV and
osteogenic differentiation factors (Fig. 3). To characterize
at molecular level this effect, we analyzed the expression of
signaling and structural protein markers of the osteogenic
differentiation [33]. Western blotting showed that RUNX2,
the transcription factor of osteocalcin (OCN) and of other
genes associated with osteoblast differentiation, [34, 35]
was upregulated in the HGMSCs cultured in the differenti-
ation medium or in the presence of RV alone (though to a
lower extent in the latter case) (Fig. 4). Interestingly, when
RV was added to the differentiation medium, the expres-
sion of RUNX2 was further induced compared to the cul-
ture conditions in either the differentiation medium or RV
Fig. 2 Resveratrol promotes the osteoblastic differentiation of Human Gingival Mesenchymal Stem Cells. Adherent HGMSCs were cultured for 21
days in control medium supplemented or not with resveratrol (RV) at the indicated concentration or in differentiation medium (Diff) containing
the three osteoblastic inductive factors dexamethasone, β- glycerophosphate and ascorbic acid. At the end, the cultures were processed for
Alizarin Red S staining of extracellular calcium deposits. The stained area was quantified using the ImageJ software
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alone (Fig. 4). The combined expression of collagen 1
(COL1A1) and of osteopontin (OPN) is suggestive of differ-
entiation of MSCs toward the osteogenic line, while OCN
synthesis is switched on in osteoblasts and its expression is
therefore proofing that osteoblast differentiation indeed oc-
curred [33]. Compared to the osteogenic inductive factors,
RV alone elicited a slight increase in the expression of these
markers (Fig. 4). However, when RV was added to the
osteogenic differentiation medium it greatly stimulated the
expression of these three proteins in a synergistic manner
with the osteogenic factors (Fig. 4). To prove further the ac-
quisition of an osteogenic phenotype by HGMSCs under
these culture conditions, we performed the immunofluores-
cence co-staining of the above markers. Representative im-
ages and their quantification are shown in Fig. 5. The data
confirm that after 21 days of treatment with 1 μM RV alone
the expression of these markers was weakly induced, while
the addition of RV to the osteogenic differentiation medium
Fig. 3 Resveratrol synergizes with osteogenic inductive factors to accelerate osteoblastic differentiation of Human Gingival Mesenchymal Stem
Cells. Adherent HGMSCs were cultured for 1 to 21 days in control medium or in differentiation medium (Diff) supplemented or not with 1 μM
resveratrol (RV). At the end, the cultures were processed for Alizarin Red S staining of extracellular calcium deposits. Quantification of stained area
in the time-course is reported in the histogram
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synergistically augmented their expression in the cells.
Noteworthy, RV greatly stimulated the nuclear transloca-
tion of RUNX2 (Fig. 5a).
Osteogenic differentiation of human gingival mesenchymal
stem cells associates with induction of autophagy
To see if autophagy is involved in the osteogenic
differentiation of HGMSCs we first performed the
immunofluorescence staining of autophagic vacuoles with
antibodies specific to LC3, a lipidated protein specifically
associated with the membranes of the autophagosomes,
and to LAMP1, an integral protein of the lysosomal mem-
branes [36]. The co-labeling marks the autolysosome and
is indicative of the effective fusion of autophagosomes with
lysosomes. Representative images taken at day 1 and day
21 are shown in Fig. 6. ImageJ quantification of co-labeled
Fig. 4 Expression of osteoblastic differentiation markers in Human Gingival Mesenchymal Stem Cells. Adherent HGMSCs were cultured for 21 days in
control medium or in differentiation medium (Diff) supplemented or not with 1 μM resveratrol (RV). At the end, cell homogenates were processed for
western blotting analysis of the expression of the osteoblastic transcription factor RUNX-2 and of the osteogenic differentiation markers COL1A1, OPN
and OCN. Densitometry of the specific bands (average ± S.D.) of three independent experiments is shown in the histograms
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vesicles (autolysosomes) indicated that the autophagy flux
was greatly and promptly (since day 1) stimulated by RV,
while it was initially (at day 1) downregulated and later (at
day 21) induced by the osteogenic differentiation factors.
Remarkably, the formation and accumulation of autolyso-
somes were greatly stimulated in the cells cultured in dif-
ferentiation medium supplemented with RV (Fig. 6). As a
further proof of the induction of autophagy during
HGMSCs differentiation, we analyzed the AMPK-
BECLIN-1 pathway, as primary candidate of the signaling
pathway triggered by RV [37]. It was found that under
osteogenic inductive culture conditions AMPK was active
and, particularly, BECLIN-1 was synergistically activated
by the combination of RV and osteogenic differentiation
Fig. 5 Immunofluorescence staining of osteoblastic differentiation markers in Human Gingival Mesenchymal Stem Cells. HGMSCs were plated on
sterile coverslips, let adhere and cultured for 21 days in control medium or in differentiation medium (Diff) supplemented or not with 1 μM
resveratrol (RV). At the end, the coverslips were fixed and processed for immunofluorescence staining of the osteogenic differentiation markers.
Fluorescence staining was quantified with the ImageJ software
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factors (Fig. 7). It is to be noted that by day 21, when the
culture reached confluency and osteoblastic differentiation
almost reached completion, the AMPK-BECLIN-1 path-
way was switched off (Fig. 7).
Inhibition of BECLIN-1-depedent autophagy impairs
osteogenic differentiation of HGMSCs by resveratrol
Finally, we investigated whether autophagy was actively
involved in the differentiation process or it was just an
accompanying epiphenomenon. To this end, we moni-
tored the occurrence of osteogenic differentiation in
HGMSCs cultivated in the presence of spautin-1, a po-
tent inhibitor of autophagy that promotes the prote-
asome-mediated degradation of BECLIN-1 [38]. We first
determined the appropriate concentration of spautin-1
that could inhibit chronically (for 21 days) autophagy
with no toxic side effect on HGMSCs cell viability (data
not shown). 5 μM Spautin-1 effectively depleted the cell
Fig. 6 Osteoblastic differentiation of Human Gingival Mesenchymal Stem Cells associates with induction of autophagy. HGMSCs were plated on
sterile coverslips, let adhere and cultured for 1 to 21 days in control medium or in differentiation medium (Diff) supplemented or not with 1 μM
resveratrol (RV). At the end, the coverslips were fixed and processed for immunofluorescence staining of the autophagy markers LC3 (marker of
autophagosomes) and LAMP1 (marker of lysosomes). Fluorescence staining was quantified with the ImageJ software. Integrated fluorescence
intensity of co-labeled area (yellow) was calculated and reported in histograms
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of BECLIN-1 (Fig. 8a), resulting in a strong inhibition of
autophagy as shown by the impaired conversion of LC3-
I into LC3-II (Fig. 8b). This was further confirmed by
the lack of interaction between BECLIN-1 and Vps34
(aka PI3KC3) in the cells cultivated in RV-supplemented
differentiation medium in the presence of spautin-1, as
shown by immunofluorescence co-staining (Fig. 8c).
Next, we searched for the mechanistic link between au-
tophagy and osteogenic differentiation. The chronic in-
cubation in differentiation medium supplemented with
RV led to the synthesis and accumulation of OCN in the
cells with upregulated autophagy, as indicated by the
presence of LC3-positive dots (Fig. 9a). However, in the
parallel cultures co-treated with spautin-1 the number of
LC3-positive dots per cell was greatly reduced to the
level in controls and the OCN staining was faintly visible
(Fig. 9a). Similarly, intense fluorescent staining of OCN
and COL1A1 was apparent in the cells cultivated in RV-
supplemented differentiation medium, while it was no
apparent in the parallel culture co-treated with Sp-1 (Fig.
9b). From a functional point of view, spautin-1 inhibition
of autophagy resulted in impaired mineralization of the
extracellular matrix, as indicated by the lack of Ali-
zarin Red-positive deposits of calcium (Fig. 9c). Add-
itionally, western blotting of RUNX2, COL1A1, OPN
and OCN showed that the expression of these
Fig. 7 Osteoblastic differentiation of Human Gingival Mesenchymal Stem Cells associates with modulation of the AMPK-BECLIN-1 autophagy
signaling pathway. HGMSCs were cultured for 1 to 21 days in control medium or in differentiation medium (Diff) supplemented or not with 1 μM
resveratrol (RV). At the end, cell homogenates were processed for western blotting analysis of the expression of activated (phosphorylated) AMPK
and BECLIN-1, two signaling proteins that govern autophagy. Densitometry (arbitrary units) is included. Similar data were reproduced in another
independent experiment
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Fig. 8 Spautin-1 abrogates induction of BECLIN-1-dependent autophagy in Human Gingival Mesenchymal Stem Cells cultivated in osteoblastic
differentiation condition. HGMSCs were cultured for 21 days in control medium or in differentiation medium supplemented with 1 μM resveratrol
(Diff + RV) in the absence or in the presence of spautin-1 (Sp1). At the end, cell homogenates were processed for western blotting analysis of the
expression of a BECLIN-1 (target of spautin-1) and of b LC3 (marker of autophagosome). Densitometry (arbitrary units) of the specific bands is
included. Data were reproduced in three independent experiments. The ratio LC3-II/LC3-I is assumed as an index of autophagosome and
autolysosome accumulation in the cell. c HGMSCs were plated on sterile coverslips, let adhere and cultured for 21 days in control medium or in
differentiation medium supplemented with 1 μM resveratrol (Diff + RV) in the absence or the presence of spautin-1 (Sp1). At the end, the
coverslips were fixed and processed for immunofluorescence staining of the autophagy interactome markers Vps34 (PI3KC3) and BECLIN-1.
Fluorescence staining was quantified with the ImageJ software. Integrated fluorescence intensity of co-labeled area (yellow) was calculated and
reported in histograms. Data from three coverslips per condition reproduced in three separate experiments
Vidoni et al. Cell Communication and Signaling           (2019) 17:98 Page 11 of 17
markers of osteogenic differentiation was completely
prevented in the cultures exposed to Sp-1 despite the
concomitant presence in the medium of RV and
osteogenic inductive factors (Fig. 10). From these data
we may conclude that autophagy is functionally linked
to osteogenic differentiation of HGMSCs.
Discussion
Autophagy is the major pathway for the cellular bulk
degradation associated with the remodeling of cellular
structures during differentiation of MSCs [23, 24].
During cellular differentiation, the autophagy pathway
is finely tuned to meet the metabolic needs associated
with the morpho-functional changes [22]. Two princi-
pal signaling pathways converging on the ULK1 com-
plex control autophagy: the mTORC1 pathway, with
inhibitory function, and the AMPK pathway, with acti-
vating function [39]. The mTORC1 pathway is posi-
tively triggered by growth factors and availability of
nutrients, the AMPK pathway is activated when there is
a lack of ATP production because of lack of nutrients
or mitochondrial poisoning [40]. The AMPK-ULK1
pathway was shown to positively regulate autophagy-
dependent mitochondrial homeostasis in embryonic
stem cells, contributing to stemness properties [41].
Consistently, autophagy plays a role in maintaining the
stemness properties and is modulated during stem cell
differentiation [42]. In this work, we analyzed the con-
tribution of autophagy in the osteoblastic differenti-
ation of HGMSCs induced by RV or the osteoblastic
inductive factors dexamethasone, β-glycerophosphate
and ascorbic acid or their combination. We
Fig. 9 Spautin-1 prevents the autophagy-associated osteoblastic differentiation of Human Gingival Mesenchymal Stem cells. a HGMSCs were
plated on sterile coverslips, let adhere and cultured for 21 days in control medium or in differentiation medium supplemented with 1 μM
resveratrol (Diff + RV) in the absence or the presence of spautin-1 (Sp1). The coverslips were then fixed and processed for immunofluorescence
staining of the autophagy marker LC3 and of the osteoblastic differentiation marker OCN. As an index of autophagy in the cells, LC3 puncta were
quantified (as per the guidelines 36). b HGMSCs were plated and treated as in a and the coverslips processed for immunofluorescence staining of
the osteoblastic differentiation markers OCN and COL1A1. Integrated fluorescence intensity quantified with the ImageJ software is shown in the
histograms. c HGMSCs cells were plated on plastic and treated as in a and at the end the cultures were processed for Alizarin Red S staining of
extracellular calcium deposits. The stained area was quantified using the ImageJ software
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demonstrate that RV induces the osteoblastic differenti-
ation of HGMSCs when used at 1 μM, while it is toxic
at concentrations above 10 μM. Our results are in
agreement with similar studies conducted on human
bone-derived MSCs [17] and human embryonic stem
cells [18]. Compared to the osteogenic inductive fac-
tors, RV elicited a less pronounced differentiation by
day 21. It is likely that prolonging the incubation with
RV would eventually attain a full osteoblastic differenti-
ation. RV induced the expression and promoted the nu-
clear translocation of the osteogenic transcription
factor RUNX2. Remarkably, RV synergized with the
osteogenic inductive factors accelerating the osteo-
blastic differentiation of HGMSCs, as indicated by
Fig. 10 Spautin-1 prevents the expression of osteoblastic differentiation markers in Human Gingival Mesenchymal Stem cells. HGMSCs were
cultured for 21 days in control medium or in differentiation medium supplemented with 1 μM resveratrol (Diff + RV) in the absence or in the
presence of spautin-1 (Sp1). At the end, cell homogenates were processed for western blotting analysis of the expression of the osteoblastic
transcription factor RUNX-2 and of the osteogenic differentiation markers COL1A1, OPN and OCN. Densitometry of the specific bands (average ±
S.D.) of three independent experiments is shown in the histograms
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anticipation and increased mineralization of the extra-
cellular matrix. Signs of osteoblastic differentiation
such as OCN synthesis and extracellular calcium de-
posits became detectable after 7 days of culture.
Osteoblastic differentiation of HGMSCs was strictly
dependent on BECLIN-1 dependent autophagy, as dem-
onstrated by the observation that it was prevented by
spautin-1 induced depletion of BECLIN-1 and conse-
quent inhibition of autophagy. It is likely that RV accel-
erated the osteoblastic differentiation of HGMSCs
cultivated in the osteogenic differentiation medium be-
cause of its strong stimulation of autophagy. RV has
been shown to induce autophagy in mouse embryonic
stem cells via activation of the AMPK/ULK1 pathway,
and this correlated with enhanced pluripotency of the
cells [37]. RV mimics a situation of energy restriction
and activates the AMPK pathway regardless of the pres-
ence of nutrients, leading to activation of autophagy
[27]. Activation of AMPK bypasses the block by
mTORC1 and triggers autophagy through direct acti-
vating phosphorylation of ULK1 and of BECLIN-1 [43,
44]. Under metabolic stress conditions, the parallel acti-
vation of mTOR and of AMPK allows the coordinated
and contemporary protein degradation and protein syn-
thesis processes, with the former providing the amino
acids needed for the latter [45]. We observed that
AMPK was transitorily activated in HGMSCs undergo-
ing cell differentiation and it was down-regulated when
osteoblastic differentiation was achieved. This same
pattern was paralleled by phosphorylated Ser93
BECLIN-1, which is operated by AMPK [44]. Modula-
tion of AMPK activation drives osteoblast differenti-
ation: it is induced during early differentiation and its
silencing or inhibition causes bone loss, yet its constitu-
tive activation prevents full differentiation [46]. This
modulation was paralleled by modulation of autophagy,
suggesting that down-regulation of AMPK-dependent
autophagy could favor glycolysis, which is necessary in
the late stages of differentiation [46]. Interestingly,
similar findings were reported in the myoblast to myo-
tube differentiation of muscle satellite cells, which are
regarded as stem-like cells [47]. Thus, down-regulation
of the AMPK-BECLIN-1 pathway is consistent with the
progressive downregulation of autophagy to basal levels
once that full differentiation is achieved when it is no
more requested the degradation of redundant or un-
wanted cell components.
Conclusions
In summary, here, we provide for the first time the
evidence that RV and osteogenic inductive factors syner-
gize to induce the osteoblastic differentiation of HGMSCs
and that this process relies on modulation of autophagy.
Human gingiva represents an abundant and easily
accessible source of MSCs. The possibility of inducing the
differentiation of HGMSCs in an osteogenic sense in vitro
can be translated into the regenerative cell therapy of
maxillary / mandibular bone defects [5, 6, 48]. Inductive
factors such as RV and autophagy modulators can be
incorporated into scaffold nanostructures containing
HGMSCs and be implanted in situ for repairing and
reconstructive purposes) [49].
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